The Gene Business : Who Should Control Biotechnology?
The Gene Business examines the use of genetic engineering and molecular biology by companies for profit. Alarmed by the possible long-term effects of corporate controlled university research, where decisions are made by expedient and sometimes short-sighted board members, Yoxen gives an account of how genetic engineering evolved from pure science to profitable business. He looks at the structure, function and effects of today's multinational gene business, and its scientific, economic, social and political implications.
- Paperback | 240 pages
- 29 May 1986
- Oxford University Press Inc
- New York, United States